Milk fatty acids as possible biomarkers to early diagnose elevated concentrations of blood plasma nonesterified fatty acids in dairy cows

Most cows encounter a state of negative energy balance during the periparturient period, which may lead to metabolic disorders and impaired fertility. The aim of this study was to assess the potential of milk fatty acids as diagnostic tools of detrimental levels of blood plasma nonesterified fatty acids (NEFA), defined as NEFA concentrations beyond 0.6 mmol/L, in a data set of 92 early lactating cows fed a glucogenic or lipogenic diet and subjected to 0-, 30-, or 60-d dry period before parturition. Milk was collected in wk 2, 3, 4, and 8 (n = 368) and blood was sampled weekly from wk 2 to 8 after parturition. Milk was analyzed for milk fatty acids and blood plasma for NEFA. Data were classified as "at risk of detrimental blood plasma NEFA" (NEFA ≥ 0.6 mmol/L) and "not at risk of detrimental blood plasma NEFA" (NEFA <0.6 mmol/L). Concentrations of 45 milk fatty acids and milk fat C18:1 cis-9-to-C15:0 ratio were subjected to a discriminant analysis. Milk fat C18:1 cis-9 revealed the most discriminating variable to identify detrimental blood plasma NEFA. A false positive rate of 10% allowed us to diagnose 46% of the detrimental blood plasma NEFA cases based on a milk fat C18:1 cis-9 concentration of at least 230 g/kg of milk fatty acids. Additionally, it was assessed whether the milk fat C18:1 cis-9 concentrations of wk 2 could be used as an early warning for detrimental blood plasma NEFA risk during the first 8 wk in lactation. Cows with at least 240 g/kg of C18:1 cis-9 in milk fat had about 50% chance to encounter blood plasma NEFA values of 0.6 mmol/L or more during the first 8 wk of lactation, with a false positive rate of 11.4%. Profit simulations were based on costs for cows suffering from detrimental blood plasma NEFA, and costs for preventive treatment based on daily dosing of propylene glycol for 3 wk. Given the relatively low incidence rate (8% of all observations), continuous monitoring of milk fatty acids during the first 8 wk of lactation to diagnose detrimental blood plasma NEFA does not seem cost effective. On the contrary, milk fat C18:1 cis-9 of the second lactation week could be an early warning of cows at risk of detrimental blood NEFA. In this case, selective treatment may be cost effective.

[Klinik und Diagnose von Hypogonadismus und Andropause]

Diagnosis and therapy of male hypogonadism is still a challenge because of the unspecific clinical signs and symptoms. The clinical presentation of a androgen deficiency is age-related. In the adult men, one can often observe fatigue, decrease in physical capacity, loss of libido and erectile dysfunction. At the physical examination, genitalia have always to be assessed in search of a testes/penis atrophy. Two fasting measurements of total testosterone concentrations by a reliable assay are needed to confirm the diagnosis. By assessing gonadotropines the origin of hypogonadism can be determined (central/secondary or peripheral/primary). Exogenous administration of androgens should be considered in young, sportive, healthy and muscular males. Patients with metabolic syndrome should only be screened for hypogonadism in the presence of suggestive symptoms. Prostate disease, hematocrit higher than 50 %, uncontrolled heart failure and severe obstructive sleep apnea are contraindications of a testosterone replacement therapy. Patients with metabolic-syndrome-associated low testosterone levels should firstly benefit from a lifestyle intervention that can normalize clinical and biochemical hypogonadism. So far, there is no clear evidence for a possible benefit of testosterone therapy in patients with the metabolic syndrome. Similarly, in patients with PADAM (partial androgen deficiency of the aging male) testosterone therapy is not established or recommended.

Marfan-Syndrom: Wissenswertes zu Diagnose und Therapie für die Praxis

• Das M arfan-Syndrom ist die häufigste h ereditäre Bindegewebskrankheit mit einer Häufigkeit (Prävalenz) von etwa 1:5000. • Die Ursache ist eine Mutation im FBN1-Gen. Die Vererbung erfolgt autosomal- dominant, bei etwa 30% der Fälle handelt es sich um de novo FBN1-Mutationen. • Die Hauptmanifestationen des Marfan-Syndroms sind: Aortendilatation, Mitralklappenprolaps, Augenveränderungen (Linsensubluxation) und Skelettveränderungen ( Skoliose, Thoraxasymmetrie, Platt- u nd/oder Senkfüsse, Arachnodaktylie). • Ziel einer frühzeitigen Diagnose ist die Verminderung des Risikos katastrophaler Aortendissektionen. Dies wird erreicht durch eine frühzeitige korrekte Diagnose sowie darauf basierend durch einen entsprechenden Lebensstil zur Vermeidung von hohen Blutdruckbelastungen, eine prophylaktische Behandlung mit Betablockern/Angiotensin-II-Antagonisten und den frühzeitigen prothetischen Ersatz dilatierter Aortenabschnitte.

Eine (nicht ganz) unerwartete Diagnose

Die Zuweisung eines 50-jährigen Patienten mit seronegativer Spondarthritis auf die pneumologische Abteilung erfolgte durch den be­han­delnden Rheumatologen bei linksseitigem Pleuraerguss und Konversion im interferon-gamma release assay (IGRA).

An analysis of IN.PACT DEEP randomized trial on the limitations of the societal guidelines-recommended hemodynamic parameters to diagnose critical limb ischemia.

OBJECTIVE Recent small single-center data indicate that the current hemodynamic parameters used to diagnose critical limb ischemia are insensitive. We investigated the validity of the societal guidelines-recommended hemodynamic parameters against core laboratory-adjudicated angiographic data from the multicenter IN.PACT DEEP (RandomIzed AmPhirion DEEP DEB vs StAndard PTA for the treatment of below the knee Critical limb ischemia) Trial. METHODS Of the 358 patients in the IN.PACT DEEP Trial to assess drug-eluting balloon vs standard balloon angioplasty for infrapopliteal disease, 237 had isolated infrapopliteal disease with an available ankle-brachial index (ABI), and only 40 of the latter had available toe pressure measurements. The associations between ABI, ankle pressure, and toe pressure with tibial runoff, Rutherford category, and plantar arch were examined according to the cutoff points recommended by the societal guidelines. Abnormal tibial runoff was defined as severely stenotic (≥70%) or occluded and scored as one-, two-, or three-vessel disease. A stenotic or occluded plantar arch was considered abnormal. RESULTS Only 14 of 237 patients (6%) had an ABI <0.4. Abnormal ankle pressure, defined as <50 mm Hg if Rutherford category 4 and <70 mm Hg if Rutherford category 5 or 6, was found only in 37 patients (16%). Abnormal toe pressure, defined as <30 mm Hg if Rutherford category 4 and <50 mm Hg if Rutherford category 5 or 6, was found in 24 of 40 patients (60%) with available measurements. Importantly, 29% of these 24 patients had an ABI within normal reference ranges. A univariate multinomial logistic regression found no association between the above hemodynamic parameters and the number of diseased infrapopliteal vessels. However, there was a significant paradoxic association where patients with Rutherford category 6 had higher ABI and ankle pressure than those with Rutherford category 5. Similarly, there was no association between ABI and pedal arch patency. CONCLUSIONS The current recommended hemodynamic parameters fail to identify a significant portion of patients with lower extremity ulcers and angiographically proven severe disease. Toe pressure has better sensitivity and should be considered in all patients with critical limb ischemia.

Foliar fungal pathogens and grassland biodiversity

By attacking plants, herbivorous mammals, insects, and belowground pathogens are known to play an important role in maintaining biodiversity in grasslands. Foliar fungal pathogens are ubiquitous in grassland ecosystems, but little is known about their role as drivers of community composition and diversity. Here we excluded foliar fungal pathogens from perennial grassland by using fungicide to determine the effect of natural levels of disease on an otherwise undisturbed plant community. Importantly, we excluded foliar fungal pathogens along with rabbits, insects, and mollusks in a full factorial design, which allowed a comparison of pathogen effects along with those of better studied plant enemies. This revealed that fungal pathogens substantially reduced aboveground plant biomass and promoted plant diversity and that this especially benefited legumes. The scale of pathogen effects on productivity and biodiversity was similar to that of rabbits and insects, but different plant species responded to the exclusion of the three plant enemies. These results suggest that theories of plant coexistence and management of biodiversity in grasslands should consider foliar fungal pathogens as potentially important drivers of community composition.

Effectiveness of Foliar Fungicides by Timing on Hybrid Corn

Fungicides were rarely used on hybrid corn prior to 2007, however, in the past few years, some farmers have included fungicides in their common crop production, particularly as the value of grain has increased. Fungicides are recommended for foliar disease management to protect yield potential. There also have been reports of increased yields in the absence of disease. A number of fungicides are registered for use on corn. The objectives of this project were to evaluate the yield response of hybrid corn to foliar fungicide application at various timings.

Evaluation of Foliar Fungicides and Insecticides on Soybean

Use of foliar fungicides and insecticides are an effective strategy for managing foliar diseases on soybean. There are many different fungicides and insecticides available for use currently in Iowa. Iowa State University personnel assessed the success of fungicides and insecticides across Iowa. This study was conducted at six locations: Sutherland (NW), Kanawha (NC), Nashua (NE), Ames (central), Crawfordsville (SE), and Lewis (SW) research farms (Figure 1).

Effectiveness of Foliar Fungicides by Timing on Hybrid Corn

Fungicide use on hybrid corn has increased considerably in the past four growing seasons primarily due to reports of increased yields, even in the absence of disease and higher corn prices. A number of fungicides are registered for use on corn. The objectives of this project were to 1) assess the effect of timing of application of fungicides on standability, 2) evaluate the yield response of hybrid corn to foliar fungicide application, and 3) to discern differences, if any, between fungicide products.

Evaluation of Foliar Fungicides and Insecticides on Soybeans

Use of foliar fungicides and insecticides are an effective strategy for managing foliar diseases of soybean. There are many different fungicides and insecticides available for use currently in Iowa. Iowa State University personnel assessed the success of fungicides and insecticides across Iowa. This study was conducted at six locations: Sutherland (NW), Kanawha (NC), Nashua (NE), Ames (central), Crawfordsville (SE), and Lewis (SW) research farms (Figure 1).

Effectiveness of Foliar Fungicides by Timing on Hybrid Corn in Iowa

Fungicide use on hybrid corn has increased considerably in the past three growing seasons primarily due to reports of increased yields, even in the absence of disease and higher corn prices. A number of fungicides are registered for use on corn. The objectives of this project were to 1) evaluate the yield response of hybrid corn to foliar fungicide application, 2) compare the yield response of various products and timing of application, and 3) to assess the effect of fungicide application on stalk rot development.

Evaluation of Foliar Fungicides and Insecticides on Soybeans

Use of foliar fungicides and insecticides are an effective strategy for managing foliar diseases of soybean. There are many different fungicides and insecticides available for use currently in Iowa. Iowa State University personnel assessed the success of fungicides and insecticides across Iowa. This study was conducted at six locations: Sutherland (NW), Kanawha (NC), Nashua (NE), Ames (central), Crawfordsville (SE), and Lewis (SW) research farms (Figure 1).